{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Limb-Girdle+Muscular+Dystrophies", "query": { "condition": "Limb-Girdle Muscular Dystrophies" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 45, "total_pages": 5, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Limb-Girdle+Muscular+Dystrophies&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-06-10T12:04:56.767Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00893334", "title": "Evaluation of Limb-Girdle Muscular Dystrophy", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Becker Muscular Dystrophy", "Limb-Girdle Muscular Dystrophy, Type 2A (Calpain-3 Deficiency)", "Limb-Girdle Muscular Dystrophy, Type 2B (Miyoshi Myopathy, Dysferlin Deficiency)", "Limb-Girdle Muscular Dystrophy, Type 2I (FKRP-deficiency)" ], "interventions": [], "intervention_types": [], "sponsor": "Cooperative International Neuromuscular Research Group", "sponsor_class": "NETWORK", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 60, "start_date": "2009-04", "completion_date": "2013-12", "has_results": false, "last_update_posted_date": "2014-03-07", "last_synced_at": "2026-06-10T12:04:56.767Z", "location_count": 2, "location_summary": "Washington D.C., District of Columbia • Charlotte, North Carolina", "locations": [ { "city": "Washington D.C.", "state": "District of Columbia" }, { "city": "Charlotte", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT00893334" }, { "nct_id": "NCT01740908", "title": "Stem Cell Quantification In Peripheral Blood After Hyperbaric Oxygen Therapy Treatments", "overall_status": "UNKNOWN", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Changes in Peripheral Blood Population Numbers and Type." ], "interventions": [ { "name": "Hyperbaric Oxygen Treatment", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Restorix Research Institute, LLLP", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 8, "start_date": "2012-12", "completion_date": "2013-01", "has_results": false, "last_update_posted_date": "2012-12-04", "last_synced_at": "2026-06-10T12:04:56.767Z", "location_count": 1, "location_summary": "Anacortes, Washington", "locations": [ { "city": "Anacortes", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT01740908" }, { "nct_id": "NCT03981289", "title": "Defining Clinical Endpoints in Limb Girdle Muscular Dystrophy (LGMD)", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Limb Girdle Muscular Dystrophy", "Muscular Dystrophies" ], "interventions": [], "intervention_types": [], "sponsor": "Virginia Commonwealth University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "4 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "4 Years to 65 Years" }, "enrollment_count": 116, "start_date": "2019-06-14", "completion_date": "2025-06-30", "has_results": false, "last_update_posted_date": "2026-02-27", "last_synced_at": "2026-06-10T12:04:56.767Z", "location_count": 9, "location_summary": "Irvine, California • Aurora, Colorado • Iowa City, Iowa + 6 more", "locations": [ { "city": "Irvine", "state": "California" }, { "city": "Aurora", "state": "Colorado" }, { "city": "Iowa City", "state": "Iowa" }, { "city": "Kansas City", "state": "Kansas" }, { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT03981289" }, { "nct_id": "NCT02841267", "title": "A Trial of PF-06252616 in Ambulatory Participants With LGMD2I", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "LGMD2I" ], "interventions": [ { "name": "PF 06252616", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Kathryn Wagner", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "99 Years", "sex": "ALL", "summary": "18 Years to 99 Years" }, "enrollment_count": 19, "start_date": "2016-07", "completion_date": "2019-01", "has_results": true, "last_update_posted_date": "2020-10-19", "last_synced_at": "2026-06-10T12:04:56.767Z", "location_count": 1, "location_summary": "Baltimore, Maryland", "locations": [ { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT02841267" }, { "nct_id": "NCT03488784", "title": "Natural History of Limb Girdle Muscular Dystrophy Type 2A and Type 2E", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Limb-Girdle Muscular Dystrophy Type 2A", "Limb-Girdle Muscular Dystrophy, Type 2E" ], "interventions": [], "intervention_types": [], "sponsor": "Lindsay Alfano", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 100, "start_date": "2016-11-29", "completion_date": "2025-08-11", "has_results": false, "last_update_posted_date": "2025-08-14", "last_synced_at": "2026-06-10T12:04:56.767Z", "location_count": 1, "location_summary": "Columbus, Ohio", "locations": [ { "city": "Columbus", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT03488784" }, { "nct_id": "NCT05876780", "title": "A Gene Transfer Single Dose Study to Evaluate the Safety, Tolerability and Efficacy of SRP-9003 in Non-Ambulatory and Ambulatory Participants With Limb Girdle Muscular Dystrophy, Type 2E/R4 (Beta-Sarcoglycan [β-SG] Deficiency)", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Limb Girdle Muscular Dystrophy" ], "interventions": [ { "name": "SRP-9003", "type": "GENETIC" } ], "intervention_types": [ "GENETIC" ], "sponsor": "Sarepta Therapeutics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "4 Years", "maximum_age": "50 Years", "sex": "ALL", "summary": "4 Years to 50 Years" }, "enrollment_count": 6, "start_date": "2022-12-19", "completion_date": "2028-08-28", "has_results": false, "last_update_posted_date": "2026-02-19", "last_synced_at": "2026-06-10T12:04:56.767Z", "location_count": 2, "location_summary": "Columbus, Ohio • Memphis, Tennessee", "locations": [ { "city": "Columbus", "state": "Ohio" }, { "city": "Memphis", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT05876780" }, { "nct_id": "NCT04054375", "title": "Weekly Steroids in Muscular Dystrophy", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Limb-girdle Muscular Dystrophy", "Becker Muscular Dystrophy" ], "interventions": [ { "name": "Prednisone", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Northwestern University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 20, "start_date": "2019-07-01", "completion_date": "2022-03-01", "has_results": true, "last_update_posted_date": "2023-09-21", "last_synced_at": "2026-06-10T12:04:56.767Z", "location_count": 1, "location_summary": "Chicago, Illinois", "locations": [ { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT04054375" }, { "nct_id": "NCT05902351", "title": "Natural History Study for Charcot Marie Tooth Disease", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Charcot-Marie-Tooth Disease", "Charcot-Marie-Tooth", "Charcot-Marie-Tooth Disease, Type IA", "Charcot-Marie-Tooth Disease Type 2A", "Charcot-Marie-Tooth Disease Type 2", "Charcot-Marie-Tooth Disease, Type 2C", "Charcot-Marie-Tooth Disease Type 2A2B", "Charcot-Marie-Tooth Disease Type 2B2", "Charcot-Marie-Tooth Disease Type 2A1", "Charcot-Marie-Tooth Disease Type 4B1", "Charcot-Marie-Tooth Disease, Type IB", "Charcot-Marie-Tooth Disease Type 2B1", "Charcot-Marie-Tooth Disease Type 2U (Diagnosis)", "Charcot-Marie-Tooth Disease Type 4A", "Charcot-Marie-Tooth Disease, Type 4A, Axonal Form", "Charcot-Marie-Tooth Disease Type 2A2A", "Charcot-Marie-Tooth Disease Type 2S (Disorder)", "Charcot-Marie-Tooth Disease and Deafness", "Charcot-Marie-Tooth Disease Type 4B2", "Charcot-Marie-Tooth Disease Type 4H", "Charcot-Marie-Tooth Disease Type 1F", "Charcot-Marie-Tooth Disease Type 4C", "Charcot-Marie-Tooth Disease Type 4E", "Charcot-Marie-Tooth Disease Type 1D", "Charcot-Marie-Tooth Disease Type 2Q (Diagnosis)", "Charcot-Marie-Tooth Disease Type 2A2", "Charcot-Marie-Tooth Disease Type 2N (Diagnosis)", "Charcot-Marie-Tooth Disease Type 2B5", "Charcot-Marie-Tooth Disease Type 2D", "Charcot-Marie-Tooth Disease Type 4D", "Charcot-Marie-Tooth Disease Type 2K", "Charcot-Marie-Tooth Disease Type 2L (Diagnosis)", "Charcot-Marie-Tooth Disease Type 2T", "Charcot-Marie-Tooth Disease Type 2I", "Charcot-Marie-Tooth Disease Type 2J", "Charcot-Marie-Tooth Disease Type 2E", "Charcot-Marie-Tooth Disease Type 2G", "Charcot-Marie-Tooth Disease Type 1C", "Charcot-Marie-Tooth Disease Type 2R", "Charcot-Marie-Tooth Disease Type 2O (Diagnosis)", "Charcot-Marie-Tooth Disease Type 2M", "Charcot-Marie-Tooth Disease Type 2P", "Charcot-Marie-Tooth Disease Type 2Y", "Charcot-Marie-Tooth Disease Type 4F (Diagnosis)", "Charcot-Marie-Tooth Disease Type 4B3", "Charcot-Marie-Tooth Disease Type 2H", "HNPP", "X-Linked Charcot-Marie-Tooth Disease" ], "interventions": [], "intervention_types": [], "sponsor": "Hereditary Neuropathy Foundation", "sponsor_class": "OTHER_GOV", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 10000, "start_date": "2013-11-01", "completion_date": "2029-12-31", "has_results": false, "last_update_posted_date": "2024-10-01", "last_synced_at": "2026-06-10T12:04:56.767Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT05902351" }, { "nct_id": "NCT06246513", "title": "A Trial to Learn More About an Experimental Gene Therapy Called Bidridistrogene Xeboparvovec (SRP-9003) as a Possible Treatment for Limb Girdle Muscular Dystrophy 2E/R4", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Limb-girdle Muscular Dystrophy" ], "interventions": [ { "name": "SRP-9003", "type": "BIOLOGICAL" }, { "name": "Glucocorticoid", "type": "DRUG" } ], "intervention_types": [ "BIOLOGICAL", "DRUG" ], "sponsor": "Sarepta Therapeutics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "4 Years", "maximum_age": null, "sex": "ALL", "summary": "4 Years and older" }, "enrollment_count": 17, "start_date": "2024-01-15", "completion_date": "2029-11-30", "has_results": false, "last_update_posted_date": "2026-03-02", "last_synced_at": "2026-06-10T12:04:56.767Z", "location_count": 4, "location_summary": "La Jolla, California • Columbus, Ohio • Philadelphia, Pennsylvania + 1 more", "locations": [ { "city": "La Jolla", "state": "California" }, { "city": "Columbus", "state": "Ohio" }, { "city": "Philadelphia", "state": "Pennsylvania" }, { "city": "Norfolk", "state": "Virginia" } ], "official_url": "https://clinicaltrials.gov/study/NCT06246513" }, { "nct_id": "NCT03492346", "title": "Limb Girdle Muscular Dystrophy Type 2E Recruitment Study", "overall_status": "UNKNOWN", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Limb-Girdle Muscular Dystrophy, Type 2E" ], "interventions": [], "intervention_types": [], "sponsor": "Nationwide Children's Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "3 Years", "maximum_age": "15 Years", "sex": "ALL", "summary": "3 Years to 15 Years" }, "enrollment_count": 25, "start_date": "2018-03-28", "completion_date": "2023-03-28", "has_results": false, "last_update_posted_date": "2023-03-06", "last_synced_at": "2026-06-10T12:04:56.767Z", "location_count": 1, "location_summary": "Columbus, Ohio", "locations": [ { "city": "Columbus", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT03492346" } ] }